Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol.
Future research will need to examine the beneficial versus the side effects of aripiprazole for treatment of alcohol dependence.
Post new comment